Concepedia

Nobuyuki Matsunaga

NM

Statistics

Publications

13

Citations

669

H-Index

12

Active since

1981

Affiliations

Takeda (Japan)(Current)

Nobuyuki Matsunaga is an author at Takeda (Japan) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1981–2020

13

Publications

13

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

Tomoyasu Ishikawa, Nobuyuki Matsunaga, H. TAWADA et al. · Bioorganic & Medicinal Chemistry · 2003 · 137 citations

, , +10

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Tomohiro Kaku, Takenori Hitaka, Akio Ojida et al. · Bioorganic & Medicinal Chemistry · 2011 · 126 citations · Full text

, , +7

Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists

Tomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora et al. · Journal of Medicinal Chemistry · 2011 · 110 citations · Full text

, , +17

Purification and Characterization of 6‐Aminohexanoic‐Acid‐Oligomer Hydrolase of <i>Flavobacterium</i> sp. KI72

Shinichi Kinoshita, Takashi Terada, Tomoyasu Taniguchi et al. · European Journal of Biochemistry · 1981 · 97 citations · Full text

, , +16

C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors

Nobuyuki Matsunaga, Tomohiro Kaku, Akio Ojida et al. · Bioorganic & Medicinal Chemistry · 2004 · 56 citations

, , +14

1–5 of 13